How much funding has PathAI raised?

PathAI has raised $251.0M in total funding, most recently a Series C round.

Who are PathAI's investors?

PathAI's investors include General Atlantic, D1 Capital Partners, Kaiser Permanente Ventures, Merck Global Health Innovation Fund, Polaris Partners, Bristol Myers Squibb.

Where is PathAI headquartered?

PathAI is headquartered in Boston, Massachusetts, United States.

What industry is PathAI in?

PathAI operates in Artificial Intelligence, Biotech, Healthcare, Life Sciences.

PathAI

Improve patient outcomes with AI-powered pathology.

Boston, United States · Founded 2016 · $251.0M raised

Artificial Intelligence

Biotech

Healthcare

Life Sciences

Headquarters: Boston, Massachusetts
Employees: 201–500
Founded: 2016
Business Model: B2B

Website: pathai.com
Total Funding: $251.0M
Last Round: $165.0M Series CMay 2021
Rounds: 4

About

PathAI is an AI-powered precision pathology company improving patient outcomes through advanced diagnostic tools and research services. Its platform leverages computer vision and deep learning to enhance accuracy in cancer detection and disease analysis, serving pharmaceutical and clinical research partners.

Summary

PathAI is an Artificial Intelligence company based in Boston, United States, founded in 2016. It has raised $251.0M in total across 4 rounds, most recently a $165.0M Series C round in May 2021. Investors include General Atlantic, D1 Capital Partners and Kaiser Permanente Ventures.

LinkedIn X (Twitter)